SRC and neoplasm: Xi et al. [13] reported that Src family kinases including Fyn mediated the activation of the Stat family containing Stat3, and Src-specific inhibitors decreased the activation of Stat3 and reduced the growth of tumor cell in squamous cell carcinoma.